CClinicalTrials.gg
CompletedNCT00433082Updated Feb 9, 2007

Metabolic Syndrome and Inflammatory Markers

An interventional study of Ramadan Fasting in Metabolic Syndrome, sponsored by Free Islamic University of Medical Sciences. Completed. Open to male participants. Per ClinicalTrials.gov, last updated 2007-02-09.

Sponsored by Free Islamic University of Medical Sciences · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Allocation
Randomized
Sex
Male
01

Study summary

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.

02

Conditions studied

  • Metabolic Syndrome

Keywords

  • Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,
  • Iran
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.

Browse Metabolic Syndrome studies →

Lead sponsor

Free Islamic University of Medical Sciences is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Males with metabolic syndrome

Exclusion criteria

Exclusion Criteria:

  • Conditions with insulin resistance including;
  • Type 2 diabetes mellitus,
  • Infections,
  • Stresses,
  • Uremia,
  • Acromegaly,
  • Glucocorticoid excess,
  • Hypertension ,
  • Cirrhosis and
  • Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)

Interventions

  • BehavioralRamadan Fasting
06

What researchers measure

Primary outcomes

  1. Measuring inflammatory markers in metabolic syndrome

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00433082
Lead sponsor
Free Islamic University of Medical Sciences
First posted
Feb 9, 2007
Start date
Aug 2006
Completion
Nov 2006
Last update
Feb 9, 2007

Study contacts

Zahra Vahdat Shariatpanahi, MD
principal investigator · Islamic Free University of Medical Science
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion